Iris Grossman PhD

Dr. Iris Grossman, Ph.D. a strategic leader with almost 20 years of Big Pharma and start-up biotech experience, leveraging Personalized Medicine approaches across the continuum of discovery, development, and market positioning. Deeply rooted in science and analytics, IIris leverages Iris medical sciences, human genetics, and Digi-/bio-marker training, to devise corporate strategies, multi-year partnerships, and effective IP-backed value propositions. Portfolios managed to span a wide variety of therapeutic areas, with particular emphasis on neurological diseases, autoimmunity, and metabolic diseases. Iris has repeatedly built and developed high-performing multi-disciplinary groups of experimentalists, data scientists, clinicians, and pharmacologists. Collaboratively, these teams have consistently delivered high-quality therapeutic and/or diagnostic results, utilizing cutting-edge innovation within a patient-centric culture.